Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 452,343Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 47Novo Nordisk A/S

02 16Novo Nordisk Pharma Ag

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Semaglutide

Brand Name : Ozempic

Dosage Form : Solution For Injection

Dosage Strength : 0.25mg

Packaging :

Approval Date : 31/05/2018

Application Number : 20180613000018

Regulatory Info : Approved

Registration Country : Sweden

blank

02

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Semaglutide

Brand Name : Ozempic

Dosage Form : Solution For Injection

Dosage Strength : 0.5mg

Packaging :

Approval Date : 31/05/2018

Application Number : 20180613000025

Regulatory Info : Approved

Registration Country : Sweden

blank

03

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Semaglutide

Brand Name : Ozempic

Dosage Form : Solution For Injection

Dosage Strength : 0.7ml/dose

Packaging :

Approval Date : 10/06/2024

Application Number : 20240216000089

Regulatory Info : Approved

Registration Country : Sweden

blank

04

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Semaglutide

Brand Name : Ozempic

Dosage Form : Solution For Injection

Dosage Strength :

Packaging :

Approval Date : 31/05/2018

Application Number : 20180613000032

Regulatory Info : Approved

Registration Country : Sweden

blank

05

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Semaglutide

Brand Name : Ozempic

Dosage Form : Solution For Injection

Dosage Strength : 2mg

Packaging :

Approval Date : 11/01/2022

Application Number : 20201230000028

Regulatory Info : Approved

Registration Country : Sweden

blank

06

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Semaglutide

Brand Name : Rybelsus

Dosage Form : Tablet

Dosage Strength : 1.5mg

Packaging :

Approval Date : 01/08/2024

Application Number : 20231006000037

Regulatory Info : Approved

Registration Country : Sweden

blank

07

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Semaglutide

Brand Name : Rybelsus

Dosage Form : Tablet

Dosage Strength : 14mg

Packaging :

Approval Date : 03/04/2020

Application Number : 20190429000102

Regulatory Info : Approved

Registration Country : Sweden

blank

08

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Semaglutide

Brand Name : Rybelsus

Dosage Form : Tablet

Dosage Strength : 25mg

Packaging :

Approval Date : 19/09/2024

Application Number : 20231009000140

Regulatory Info : Approved

Registration Country : Sweden

blank

09

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Semaglutide

Brand Name : Rybelsus

Dosage Form : Tablet

Dosage Strength :

Packaging :

Approval Date : 03/04/2020

Application Number : 20190429000089

Regulatory Info : Approved

Registration Country : Sweden

blank

10

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Semaglutide

Brand Name : Rybelsus

Dosage Form : Tablet

Dosage Strength : 4mg

Packaging :

Approval Date : 01/08/2024

Application Number : 20231006000044

Regulatory Info : Approved

Registration Country : Sweden

blank